AYTU logo

Aytu BioPharma (AYTU) EBITDA

Annual EBITDA

-$1.01 M
+$2.26 M+69.08%

June 30, 2024

Summary

Performance

1-Year Change

+69.08%

3-Year Change

+96.52%

5-Year Change

+92.83%

15-Year Change

+93.52%

AYTU EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.88%
AYTU annual EBITDA is higher than 77.88% of companies in Healthcare sector

High & Low

All-time High

-$40.50 K

3-Year Low

-$29.04 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
AYTU previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
AYTU next annual earnings announcement has not yet been scheduled

OtherAYTUprofitabilitymetrics:

Annual Revenue

$81.00 M
AYTU annual revenue is $81.00 million

Annual Net Income

-$15.84 M
AYTU annual net profit is -$15.84 million

Annual EBIT

-$9.28 M
AYTU annual earnings before interest & taxes is -$9.28 million

Annual EPS

-$2.86
AYTU annual earnings per share is -$2.86

Quarterly EBITDA

$3.92 M
+$9.90 M+165.54%

September 30, 2024

Summary

Performance

3-Month Change

+165.54%

1-Year Change

+190.15%

3-Year Change

+170.37%

5-Year Change

+130.03%

AYTU Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.39%
AYTU quarterly EBITDA is higher than 78.39% of companies in Healthcare sector

High & Low

All-time High

$5.17 M
AYTU quarterly EBITDA is currently -24.14% below its historical high of $5.17 million

3-Year Low

-$8.62 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUprofitabilitymetrics:

Quarterly Revenue

$16.57 M
AYTU quarterly revenue is $16.57 million

Quarterly Net Income

$1.47 M
AYTU quarterly net profit is $1.47 million

Quarterly EBIT

$2.49 M
AYTU quarterly earnings before interest & taxes is $2.49 million

Quarterly EPS

-$0.15
AYTU quarterly earnings per share is -$0.15

TTM EBITDA

$2.57 M
+$8.27 M+145.07%

September 30, 2024

Summary

Performance

3-Month Change

+145.07%

1-Year Change

+131.06%

3-Year Change

+107.75%

5-Year Change

+112.76%

AYTU TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.37%
AYTU TTM EBITDA is higher than 77.37% of companies in Healthcare sector

High & Low

All-time High

$5.45 M
AYTU TTM EBITDA is currently -52.86% below its historical high of $5.45 million

3-Year Low

-$39.37 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUprofitabilitymetrics:

TTM Revenue

$75.48 M
AYTU TTM revenue is $75.48 million

TTM Net Income

-$6.25 M
AYTU TTM net profit is -$6.25 million

TTM EBIT

-$5.29 M
AYTU TTM earnings before interest & taxes is -$5.29 million

TTM EPS

-$1.53
AYTU TTM earnings per share is -$1.53

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$1.01 M
AYTU annual EBITDA is -$1.01 million

Annual Net Income

-$15.84 M
AYTU annual net profit is -$15.84 million

Annual Interest Expense

$4.79 M
AYTU annual interest expense is $4.79 million

Annual Income Tax

$1.77 M
AYTU annual income tax is $1.77 million

Annual D&A

$8.27 M
AYTU annual depreciation & amortization is $8.27 million

AYTU EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+69.1%+190.2%+131.1%
3 y3 years+96.5%+170.4%+107.8%
5 y5 years+92.8%+130.0%+112.8%

AYTU EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+96.5%-24.1%+145.5%-52.9%+106.5%
5 y5-yearat high+96.5%-24.1%+130.0%-52.9%+106.5%
alltimeall time-2398.8%+96.5%-24.1%+128.4%-52.9%+106.5%

Aytu BioPharma EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.92 M(-165.5%)
$2.57 M(-145.1%)
Jun 2024
-$1.01 M(-69.1%)
-$5.98 M(+1886.7%)
-$5.70 M(-204.6%)
Mar 2024
-
-$301.00 K(-106.1%)
$5.45 M(-503.3%)
Dec 2023
-
$4.93 M(-213.4%)
-$1.35 M(-83.7%)
Sep 2023
-
-$4.35 M(-184.1%)
-$8.27 M(+152.6%)
Jun 2023
-$3.27 M(-87.4%)
$5.17 M(-172.8%)
-$3.27 M(-75.4%)
Mar 2023
-
-$7.10 M(+257.3%)
-$13.32 M(+1.6%)
Dec 2022
-
-$1.99 M(-406.6%)
-$13.11 M(-33.6%)
Sep 2022
-
$648.00 K(-113.3%)
-$19.74 M(-24.0%)
Jun 2022
-$25.96 M(-10.6%)
-$4.88 M(-29.1%)
-$25.96 M(-21.8%)
Mar 2022
-
-$6.88 M(-20.1%)
-$33.20 M(-15.7%)
Dec 2021
-
-$8.62 M(+54.8%)
-$39.37 M(+18.8%)
Sep 2021
-
-$5.57 M(-54.1%)
-$33.14 M(+13.9%)
Jun 2021
-$29.04 M(+137.9%)
-$12.13 M(-7.1%)
-$29.10 M(+44.6%)
Mar 2021
-
-$13.05 M(+445.4%)
-$20.13 M(+102.6%)
Dec 2020
-
-$2.39 M(+57.2%)
-$9.94 M(-11.5%)
Sep 2020
-
-$1.52 M(-51.9%)
-$11.22 M(-17.3%)
Jun 2020
-$12.21 M(-13.5%)
-$3.16 M(+10.5%)
-$13.57 M(-4.7%)
Mar 2020
-
-$2.86 M(-22.3%)
-$14.23 M(-4.7%)
Dec 2019
-
-$3.68 M(-4.8%)
-$14.93 M(-1.3%)
Sep 2019
-
-$3.87 M(+1.0%)
-$15.13 M(+7.1%)
Jun 2019
-$14.12 M(-7.4%)
-$3.83 M(+7.7%)
-$14.12 M(+4.6%)
Mar 2019
-
-$3.56 M(-8.3%)
-$13.50 M(-9.7%)
Dec 2018
-
-$3.88 M(+35.5%)
-$14.96 M(+3.8%)
Sep 2018
-
-$2.86 M(-10.9%)
-$14.41 M(-3.6%)
Jun 2018
-$15.25 M(-2.3%)
-$3.21 M(-35.9%)
-$14.96 M(+1.4%)
Mar 2018
-
-$5.01 M(+50.3%)
-$14.74 M(+2.9%)
Dec 2017
-
-$3.33 M(-2.1%)
-$14.33 M(-1.4%)
Sep 2017
-
-$3.40 M(+13.5%)
-$14.53 M(-6.9%)
Jun 2017
-$15.61 M(-28.4%)
-$3.00 M(-34.7%)
-$15.61 M(-40.9%)
Mar 2017
-
-$4.59 M(+30.2%)
-$26.40 M(+6.4%)
Dec 2016
-
-$3.53 M(-21.4%)
-$24.82 M(+2.3%)
Sep 2016
-
-$4.49 M(-67.5%)
-$24.27 M(+11.2%)
Jun 2016
-$21.81 M(+190.3%)
-$13.79 M(+358.5%)
-$21.81 M(+115.4%)
Mar 2016
-
-$3.01 M(+1.0%)
-$10.13 M(+13.5%)
Dec 2015
-
-$2.98 M(+46.4%)
-$8.93 M(+49.5%)
Sep 2015
-
-$2.03 M(-3.5%)
-$5.97 M(+51.3%)
DateAnnualQuarterlyTTM
Jun 2015
-$7.51 M(>+9900.0%)
-$2.11 M(+16.7%)
-$3.94 M(+113.5%)
Mar 2015
-
-$1.81 M(>+9900.0%)
-$1.85 M(+4320.8%)
Feb 2015
-
-$8200.00(-41.8%)
-$41.80 K(-21.1%)
Nov 2014
-
-$14.10 K(+46.9%)
-$53.00 K(+0.6%)
Aug 2014
-$52.70 K(-99.2%)
-$9600.00(-3.0%)
-$52.70 K(+3.3%)
Jun 2014
-$6.25 M(>+9900.0%)
-
-
May 2014
-
-$9900.00(-49.0%)
-$51.00 K(-1.5%)
Feb 2014
-
-$19.40 K(+40.6%)
-$51.80 K(+18.5%)
Nov 2013
-
-$13.80 K(+74.7%)
-$43.70 K(-7.8%)
Aug 2013
-$47.50 K(-5.4%)
-$7900.00(-26.2%)
-$47.40 K(-14.3%)
May 2013
-
-$10.70 K(-5.3%)
-$55.30 K(+2.0%)
Feb 2013
-
-$11.30 K(-35.4%)
-$54.20 K(+7.3%)
Nov 2012
-
-$17.50 K(+10.8%)
-$50.50 K(+0.6%)
Aug 2012
-$50.20 K(-60.4%)
-$15.80 K(+64.6%)
-$50.20 K(-51.5%)
May 2012
-
-$9600.00(+26.3%)
-$103.50 K(-7.8%)
Feb 2012
-
-$7600.00(-55.8%)
-$112.20 K(-13.0%)
Nov 2011
-
-$17.20 K(-75.1%)
-$129.00 K(+1.7%)
Aug 2011
-$126.90 K(+166.6%)
-$69.10 K(+277.6%)
-$126.90 K(+85.8%)
May 2011
-
-$18.30 K(-25.0%)
-$68.30 K(+11.2%)
Feb 2011
-
-$24.40 K(+61.6%)
-$61.40 K(+32.9%)
Nov 2010
-
-$15.10 K(+43.8%)
-$46.20 K(-2.7%)
Aug 2010
-$47.60 K(+0.2%)
-$10.50 K(-7.9%)
-$47.50 K(+4.9%)
May 2010
-
-$11.40 K(+23.9%)
-$45.30 K(+11.6%)
Feb 2010
-
-$9200.00(-43.9%)
-$40.60 K(-7.5%)
Nov 2009
-
-$16.40 K(+97.6%)
-$43.90 K(-7.6%)
Aug 2009
-$47.50 K(0.0%)
-$8300.00(+23.9%)
-$47.50 K(-2.9%)
May 2009
-
-$6700.00(-46.4%)
-$48.90 K(-15.0%)
Feb 2009
-
-$12.50 K(-37.5%)
-$57.50 K(+6.7%)
Nov 2008
-
-$20.00 K(+106.2%)
-$53.90 K(+13.5%)
Aug 2008
-$47.50 K(+17.3%)
-$9700.00(-36.6%)
-$47.50 K(+0.2%)
May 2008
-
-$15.30 K(+71.9%)
-$47.40 K(+7.2%)
Feb 2008
-
-$8900.00(-34.6%)
-$44.20 K(-9.2%)
Nov 2007
-
-$13.60 K(+41.7%)
-$48.70 K(+20.2%)
Aug 2007
-$40.50 K
-$9600.00(-20.7%)
-$40.50 K(+31.1%)
May 2007
-
-$12.10 K(-9.7%)
-$30.90 K(+49.3%)
Feb 2007
-
-$13.40 K(+148.1%)
-$20.70 K(+183.6%)
Nov 2006
-
-$5400.00(+184.2%)
-$7300.00(+284.2%)
May 2006
-
-$1900.00
-$1900.00

FAQ

  • What is Aytu BioPharma annual EBITDA?
  • What is the all time high annual EBITDA for Aytu BioPharma?
  • What is Aytu BioPharma annual EBITDA year-on-year change?
  • What is Aytu BioPharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Aytu BioPharma?
  • What is Aytu BioPharma quarterly EBITDA year-on-year change?
  • What is Aytu BioPharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Aytu BioPharma?
  • What is Aytu BioPharma TTM EBITDA year-on-year change?

What is Aytu BioPharma annual EBITDA?

The current annual EBITDA of AYTU is -$1.01 M

What is the all time high annual EBITDA for Aytu BioPharma?

Aytu BioPharma all-time high annual EBITDA is -$40.50 K

What is Aytu BioPharma annual EBITDA year-on-year change?

Over the past year, AYTU annual EBITDA has changed by +$2.26 M (+69.08%)

What is Aytu BioPharma quarterly EBITDA?

The current quarterly EBITDA of AYTU is $3.92 M

What is the all time high quarterly EBITDA for Aytu BioPharma?

Aytu BioPharma all-time high quarterly EBITDA is $5.17 M

What is Aytu BioPharma quarterly EBITDA year-on-year change?

Over the past year, AYTU quarterly EBITDA has changed by +$8.27 M (+190.15%)

What is Aytu BioPharma TTM EBITDA?

The current TTM EBITDA of AYTU is $2.57 M

What is the all time high TTM EBITDA for Aytu BioPharma?

Aytu BioPharma all-time high TTM EBITDA is $5.45 M

What is Aytu BioPharma TTM EBITDA year-on-year change?

Over the past year, AYTU TTM EBITDA has changed by +$10.84 M (+131.06%)